Basilea Pharmaceutica (BPMUF)
(Delayed Data from OTC)
$47.00 USD
0.00 (0.00%)
Updated Jul 17, 2024 02:00 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Basilea Pharmaceutica AG [BPMUF]
Reports for Purchase
Showing records 61 - 73 ( 73 total )
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Debt Maturity Improvement; Continued Clinical Progress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Russian Federation Authorization for Cresemba Triggers Milestone; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Corporate Update Reveals Only Minor Pandemic Timeline Impact; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Cresemba Launch Down Under; Multiple 2020 Catalysts; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Cresemba sales the focus for future profitability
Provider: Edison Investment Research Limited
Analyst: JANA S
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Conference Posters Underscore Derazantinib Value Proposition; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Pre-Announced 2019 Revenues Exceed Guidance; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Multiple Advances With Oncology Pipeline; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Company: Basilea Pharmaceutica AG
Industry: Medical - Biomedical and Genetics
Oncology product portfolio to drive future growth
Provider: Edison Investment Research Limited
Analyst: JANA S